Search Results
Copy of Dr. Damon on Drug Development in AML
Dr. Damon on Drug Development in AML
Dr. Damon on Allogeneic Stem Cell Transplant in AML
Dr. Smith on the Development of Active Therapeutic Combinations in Acute Myeloid Leukemia
The role of menin inhibitors in the treatment of AML
Dr. Mannis Talks About Emerging Treatments for Acute Myeloid Leukemia
The promise of menin inhibition in AML
Dr. Takahashi on Biomarker That Predicts Development of Therapy-Related Leukemia
Metabolic adaptations to targeted therapy in FLT3 mutated acute myeloid leukaemia
Anti-CD47 antibodies for complex karyotype AML
USA and UCSF Leukemia Experience - Lloyd Damon, MD
Unanswered questions in AML: classification, the role of chemotherapy & avoiding relapse
